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Abstract
The initial response of blood exposed to an artificial surface is the adsorption of blood proteins that
triggers a number of biological reactions such as inflammation and blood coagulation. Competitive
protein adsorption plays a key role in the hemocompatibility of the surface. The synthesis of nonfouling
surfaces is therefore one of the major prerequisites for devices for biomedical applications.
Polysaccharides are the main components of the endothelial cell glycocalyx and have the ability to reduce
nonspecific protein adsorption and cell adhesion and, therefore, are generally coupled with a wide variety
of surfaces to improve their biocompatibility. We have developed a procedure for covalently binding
dextran and sodium hyaluronate (HA) on silicon wafers and we have been able to achieve a high level of
control over the surface properties of the coatings. In the present research effort we focus on a detailed
investigation of competitive bovine serum albumin (BSA) and bovine fibrinogen (Fg) adsorption on
dextran- and HA-modified silicon surfaces. Polysaccharide based biomimetic layers preferentially adsorb
BSA and, in general, strongly suppress protein adsorption with respect to bare silicon and APTESactivated silicon surfaces used as control.
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ABSTRACT
The initial response of blood exposed to an artificial surface is the adsorption of blood proteins
that triggers a number of biological reactions such as inflammation and blood coagulation.
Competitive protein adsorption plays a key role in the hemocompatibility of the surface. The
synthesis of nonfouling surfaces is therefore one of the major prerequisites for devices for
biomedical applications. Polysaccharides are the main components of the endothelial cell
glycocalyx and have the ability to reduce nonspecific protein adsorption and cell adhesion and,
therefore, are generally coupled with a wide variety of surfaces to improve their
biocompatibility. We have developed a procedure for covalently binding dextran and sodium
hyaluronate (HA) on silicon wafers and we have been able to achieve a high level of control over
the surface properties of the coatings. In the present research effort we focus on a detailed
investigation of competitive bovine serum albumin (BSA) and bovine fibrinogen (Fg) adsorption
on dextran- and HA-modified silicon surfaces. Polysaccharide based biomimetic layers
preferentially adsorb BSA and, in general, strongly suppress protein adsorption with respect to
bare silicon and APTES-activated silicon surfaces used as control.

INTRODUCTION
Polysaccharides serve as excellent coatings for devices in contact with blood since they are
compatible with biological systems and have been shown to reduce protein adsorption and cell
adhesion on synthetic surfaces [1]. We have developed a procedure for covalently binding
dextran on silicon wafers pre-activated by amine terminated APTES and we have been able to
reach a high level of control on the thickness, wettability and roughness of the coatings by
varying the molecular weight, polydispersity [2, 3] and the degree of chemical oxidation of the
dextrans [4]. We have also demonstrated that monodisperse, high molecular weight dextran
coatings applied on microcapillary glass tubes show bubble adhesion properties almost identical
to the values found for in vivo and ex vivo experiments of microvascular gas embolism [2]. More
recently we have also synthesized hyaluronic acid (hyaluronan, HA) coatings on silicon wafers
by using EDC/NHS grafting chemistry [5].
A key event, whenever a biomaterial is exposed to protein-containing fluids is the adsorption
of proteins. The exact mechanism of how polymer structure and its chemical/physical properties
influence the adsorption and activation behavior of proteins is still unknown, but it is widely
assumed that the design of new biomaterials with specific functional properties and excellent
biocompatibility is dependent on understanding the competitive adsorption of proteins to
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artificial surfaces and the subsequent adhesion and activation of cells [6,7]. In this study, an
initial investigation has been undertaken to find possible correlations between the properties of
our synthetic polysaccharide coating and protein adsorption. In published reports, the
characterization of protein adsorption onto surfaces has been accomplished using mainly
radiolabeling [7] or fluorescence labeling [8] and immunoblotting techniques [9]. One major
drawback of such methods is that they cannot be used to monitor competitive protein adsorption
from complex mixtures of proteins, or they can be used to provide only semi-quantitative
measures of competitive adsorption. Thus, the first goal of our study has been the development
of a new method for quantifying competitive protein adsorption using a novel approach to
remove all adsorbed proteins from the surface of interest. Our method involves protein
displacement by CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate)
detergent solutions and subsequent analysis of the effluent by high performance liquid
chromatography (HPLC) to separate and quantify each protein species recovered. A detailed
description and discussion of such method can be found in [10]. We validated our approach
studying competitive adsorption of bovine serum albumin (BSA) and bovine fibrinogen (Fg) on
bare and polysaccharide coated silicon wafer surfaces previously synthesized in our laboratory.
This selection was made because BSA is the most concentrated protein in plasma (ca. 40 mg/ml)
[6], while Fg is the major surface protein initiating coagulation via binding to platelets and the
adsorption of Fg molecules is commonly used as a thrombogenicity marker [6, 7]. In this report
we studied competitive BSA and Fg adsorption on five different dextran coatings obtained
varying the dextran oxidation time (0.5 h, 1h, 2 h, 4 h and 24 h) and on HA coatings. As a
control, competitive BSA and Fg adsorption studies were conducted also on bare silicon wafers
and amine terminated APTES coated silicon wafers.
We show that our dextran and HA based biomimetic layers preferentially adsorb BSA and, in
general, strongly prevent protein adsorption, suggesting that they are highly promising
candidates for application on blood-contacting medical devices.

EXPERIMENTAL DETAILS
Surface preparation and characterization
The details regarding the preparation of our dextran coatings and all the different methods of
surface characterization used (ellipsometry, water contact angle measurements, AFM, FTIR and
micro-FTIR spectroscopy, micro-Raman spectroscopy, gas bubble adhesion tests) can be found
in [2-4].
For preparing HA coatings, the etched Si surfaces were incubated in a solution comprised of
Hyaluronic Acid Sodium Salt (NaHA; chain length 3-6 million; Sigma), N-Ethyl-N’-(3dimethylaminopropyl) carbodiimide (EDC;Sigma), and N-Hydroxysuccinimide (NHS;Sigma)
[5]. The concentrations of NaHA, EDC, and NHS were kept as a control- 2mg/mL NaHA and a
ratio of 40:20, EDC: NHS. After the NaHA was dissolved in Millipore purified H2O, 1 µl of
Hydrochloric Acid (HCl; Fischer Scientific) was added to lower the pH of the NaHA + H2O
from ~6 to ~4. Once the NaHA was dissolved completely in water, EDC and NHS were added to
bring the reaction volume to 20 ml. The surfaces, prior to incubation, were immersed in
Phosphate Buffered Saline (PBS; Sigma, pH 7.4) on a shaker for ten minutes and rinsed with
purified water. The immobilization reaction proceeded at room temperature on a shaker for 20
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hours. Following the incubation time, all surfaces were washed with purified water and sonicated
for 20 minutes in purified water.
Competitive protein adsorption studies
Bovine serum albumin, lyophilized, fatty acids- and globulin-free was obtained from Sigma
Chemical Co., U.S.A., as was bovine fibrinogen (fraction I; >75% clottable protein). The
proteins were used without further purification. For both proteins, solutions were prepared with
the use of 40 mM phosphate-buffer saline (PBS) at pH 7.0. Chemicals used for the buffer
preparation were all of analytical grade, and used without further purification. Representative
physical properties of both proteins are listed in Table I
A complete description of the development and validation of a new HPLC method to study
adsorption of micrograms of proteins onto the surface of materials can be found in [10].
CHAPS (Sigma C3023) was used as surfactant agent to displace BSA and Fg from bare and
polysaccharide-coated silicon surfaces. This surfactant has been proven to be almost totally
effective (~95%) at protein desorption from our surfaces conducting parallel experiments with
Oregon Green (OG) 488 dye (Molecular Probes, Eugene, OR) labeled proteins [8,10].
Competitive protein adsorption on both control (bare and APTES functionalized silicon) and
polysaccharide coated silicon surfaces was carried out in bulk BSA and Fg solutions, both with
concentration of 20 µg/ml, for 1 hour on a shaker at 37°C. Solid substrates with adsorbed
proteins were rinsed to remove loosely bound proteins by use of protein-free PBS. The adsorbed
proteins were eluted from the surfaces by exposure to a 8 mM CHAPS solution (1 hour on a
shaker at 37°C) The eluted protein samples were first dialyzed for 24 hours at 4°C, in PBS (pH
~7) replaced 4 times to remove the CHAPS and then stored at -70°C until needed, before being
placed on a freeze-dryer overnight. The recovered proteins were finally identified and quantified
by HPLC. The chromatography experiments were conducted on a Beckman Coulter System
Gold® HPLC system (running 32 Karat™ software) comprised of a 126 pump model solvent
delivery module, a 168 programmable detector module, which is a diode array UV/Vis HPLC
detector set at 210 nm wavelength and a manual injector. Given that BSA and Fg have very
similar pI values, but very different molecular weights (see Table I), we identified and quantified
them by size exclusion chromatography (SEC), which separates biomolecules based on
differences in their molecular size. We used a bonded silica Bio-Sil SEC 250 column from BioRad. The eluent was a buffer with composition 0.05 M NaH2PO4, 0.05 M Na2HPO4, 0.15 M
NaCl and pH 6.8, the flow rate was set at 0.6 ml/min and the injection volume was 200 µl.
Calibration curves were obtained by injecting fixed volumes of standard mixtures of BSA and Fg
with known concentrations (see Figure 1).
Table I. Representative Physical Properties of Selected Proteins
protein
BSA
fibrinogen

plasma conc
mg/ml
40
2-3

mass
Da
340 000
66 000

size
nm
4×3×3
47 × 5 × 5

volume
nm3
271
3645

pI

ref

4.7
4.3

6
6
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BSA, 66 kDa

Peak at 11.9 min, Fg 340 000 Da
Peak at 16.45 min, BSA 66 000 Da
AreasPeakat1

1 µg
5 µg
10 µg
20 µg
30 µg
40 µg
50 µg

, a.u.
A
210

A210, a.u.

BSA
Fg
BSA + Fg

Peak area, a.u.

Fg, 340 kDa
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Figure 1. SEC of a standard mixture of BSA and Fg (left) and calibration curves (right). Column
and conditions as described in the text.

RESULTS AND DISCUSSION
Using our newly developed HPLC method for studying competitive protein adsorption on the
surface of materials [10], we tested the affinity towards serum BSA and Fg of bare and APTESactivated silicon substrates as controls and of six different polysaccharide modified silicon
surfaces. The five different dextranized surfaces, having varying grafting density, have been
systematically characterized [4] in an effort to correlate wettability, roughness and contact force
to surface morphology. An AFM image, taken under aqueous conditions, and a section analysis
of an HA coating are shown in Figure 2. HA is observed to uniformly attach and cover the
silicon substrate and to extend into the aqueous solution. The section analysis shows that the
surface morphology is characterized by small features, which increase the root-mean-square
surface roughness (23.3 nm) and fewer large features.

Figure 2. AFM image under aqueous conditions (left, Z scale is 60 nm) and section analysis
(right) of grafted HA. Root-mean-square surface roughness 23.3 nm, maximum height 41.6 nm.
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Figure 3. SEC of mixtures of BSA and Fg displaced from different solid substrates (for details
see the text). Column and conditions as in Figure 1.
The competitive BSA and Fg adsorption data, reported as chromatograms of the displaced
proteins in Figure 3 and converted into protein surface density in Figure 4, show that all the six
polysaccharide-modified silicon surfaces strongly suppress protein adsorption with respect to
bare silicon and APTES-activated silicon surfaces used as controls. Dextranized surfaces
suppress total protein adsorption from 65% (1 h oxidation time) to 75% (0.5 h oxidation time)
with respect to bare hydrophilic silicon and from 72% (1 h) to 80% (0.5 h) with respect to
hydrophobic APTES-grafted silicon wafers. The HA coating is even more effective at protein
rejection, lowering adsorption to 84% with respect to silicon and 88% with respect to APTES.
Dextranized and HA surfaces strongly preferentially adsorb BSA with respect to Fg. BSA
represents a percentage of the total adsorbed amount which goes from 69% (24 h oxidation
dextran) to 93% (2 h oxidation dextran). This is even more outstanding if we consider that the
adsorption took place from mixtures of BSA and Fg at the same concentration (20 µg/ml).
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Figure 4. Protein surface density on bare and APTES-activated silicon substrates as controls and
on six different polysaccharide-modified silicon surfaces. For details see the text.
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Polymers capable of preferentially adsorbing BSA are thought to be less thrombogenic than
those enriched in Fg, because BSA is inert to platelets, while fibrinogen enhances adhesion and
aggregation of platelets [11]. This initial investigation thus suggests our polysaccharide-based
coatings are highly promising candidates for applications on blood-contacting medical devices,
especially fibrinogen-inert materials for the venous system [11].

CONCLUSION
In this research effort, we investigated the efficacy of dextran and HA based biomimetic films on
silicon substrates in controlling nonspecific protein interactions. BSA and Fg competitive
adsorption studies on unmodified and polysaccharide-modified silicon surfaces indicated that
these polysaccharide films are very efficient in reducing protein adsorption. Therefore, we expect
them to show reduced cell adhesion and perform favorably in actual biological environments.
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